CIRM Deficient Again on Informing the Public and Stem Cell Community
Directors of the $3 billion California stem cell agency have scheduled a two-day meeting in San Diego next week that is chock-a-block full with complex and enormously expensive business ranging from generous grant programs to revamping reviews on its highest profile financing rounds.
That is not to mention the matter of electing a new chairman for what …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.